Intergard Synergy vascular graft (Maquet Cardiovascular) receives CE mark

Maquet Cardiovascular has received the CE mark for its Intergard Synergy vascular graft. This graft combines the antimicrobial properties of silver acetate and triclosan. Vascular graft infection, although rare, is one of the most serious complications of vascular reconstructive surgery and in vitro testing of the Intergard Synergy vascular graft demonstrates antimicrobial efficacy against a broad spectrum of micro-organisms including MRSA (Methicillin Resistant Staphylococcus Aureus). The Intergard Synergy graft will be commercially available immediately within countries that recognize the CE mark.